Search details
1.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36482190
2.
Prognostic role of sodium levels in colorectal cancer patients receiving aflibercept plus FOLFIRI.
Future Oncol
; 19(38): 2537-2546, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38050741
3.
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer.
Int J Mol Sci
; 24(6)2023 Mar 19.
Article
in English
| MEDLINE | ID: mdl-36982913
4.
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.
Int J Mol Sci
; 24(5)2023 Mar 02.
Article
in English
| MEDLINE | ID: mdl-36902306
5.
Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study.
Br J Cancer
; 125(1): 94-100, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33953347
6.
Results of the observational prospective RealFLOT study.
BMC Cancer
; 21(1): 1086, 2021 Oct 08.
Article
in English
| MEDLINE | ID: mdl-34625033
7.
Association of Systemic Steroid Treatment and Outcome in Patients Treated with Immune Checkpoint Inhibitors: A Real-World Analysis.
Molecules
; 26(19)2021 Sep 24.
Article
in English
| MEDLINE | ID: mdl-34641331
8.
Update on gastric cancer treatments and gene therapies.
Cancer Metastasis Rev
; 38(3): 537-548, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31486976
9.
Somatostatin analogs in pregnant patients with neuroendocrine tumor.
Anticancer Drugs
; 31(10): 1096-1098, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32590392
10.
Single-Agent Panitumumab in Frail Elderly Patients With Advanced RAS and BRAF Wild-Type Colorectal Cancer: Challenging Drug Label to Light Up New Hope.
Oncologist
; 20(11): 1261-5, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26446234
11.
Gallbladder neuroendocrine neoplasm: a case report and critical evaluation of WHO classification.
Endocr J
; 61(10): 989-94, 2014.
Article
in English
| MEDLINE | ID: mdl-25088492
12.
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell'Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO).
Tumori
; 110(3): 203-208, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38326240
13.
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine.
Cancers (Basel)
; 15(2)2023 Jan 08.
Article
in English
| MEDLINE | ID: mdl-36672366
14.
Clinical outcomes and response to chemotherapy in a cohort of pancreatic cancer patients with germline variants of unknown significance (VUS) in BRCA1 and BRCA2 genes.
Cancer Chemother Pharmacol
; 92(6): 501-510, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37725113
15.
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma.
Cancer Med
; 12(13): 14337-14345, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37278395
16.
Systemic Sclerosis Association with Malignancy.
Clin Rev Allergy Immunol
; 63(3): 398-416, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36121543
17.
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy.
Cancer Treat Res Commun
; 32: 100603, 2022.
Article
in English
| MEDLINE | ID: mdl-35792426
18.
Isoforms of the orphan nuclear receptor COUPTFII differentially modulate pancreatic cancer progression.
Int J Oncol
; 60(5)2022 May.
Article
in English
| MEDLINE | ID: mdl-35348189
19.
Evolving pancreatic cancer treatment: From diagnosis to healthcare management.
Crit Rev Oncol Hematol
; 169: 103571, 2022 Jan.
Article
in English
| MEDLINE | ID: mdl-34923121
20.
Aflibercept Plus FOLFIRI as Second-Line Treatment for Metastatic Colorectal Cancer: A Single-Institution Real-Life Experience.
Cancers (Basel)
; 13(15)2021 Jul 31.
Article
in English
| MEDLINE | ID: mdl-34359764